Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Glioblastoma-specific anti-TUFM nanobody for in-vitro immunoimaging and cancer stem cell targeting

2 Apr 2018

Abstract excerpt

// Neja Samec 1 , Ivana Jovcevska 1 , Jure Stojan 1 , Alja Zottel 1 , Mirjana Liovic 1 , Michael P. Myers 2 , Serge Muyldermans 3 , Jernej Šribar 4 , Igor Križaj 4 and Radovan Komel 1 1 Medical Centre for Molecular Biology, Institute of Biochemistry, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia 2 International Centre for Genetic Engineering and Biotechnology (ICGEB), Trieste, Italy 3 Cellular...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Monoclonal and Polyclonal Antibodies Research
Share to Nanoparticle-Based Drug Delivery
Share to Nanoplatforms for cancer theranostics

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 29707108
DOI: 10.18632/oncotarget.24629

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Glioblastoma-specific anti-TUFM nanobody for in-vitro immunoimaging and cancer stem cell targetingPMID 29707108Read ↗

Unravelling the Glioblastoma Tumour Microenvironment: Can Aptamer Targeted Delivery Become Successful in Treating Brain Cancers?Semantic proximity Read ↗

Gene therapy in glioblastoma multiforme: Can it be a role changer?Semantic proximity Read ↗

Systemic delivery of a CXCR4-CXCL12 signaling inhibitor encapsulated in synthetic protein nanoparticles for glioma immunotherapySemantic proximity Read ↗

Humanin activates integrin αV-TGFβ axis and leads to glioblastoma progressionSemantic proximity Read ↗

Harnessing the Cross-talk between Tumor Cells and Tumor-associated Macrophages with a Nano-drug for modulation of Glioblastoma Immune MicroenvironmentSemantic proximity Read ↗

Nanobody-based retargeting of an oncolytic herpesvirus for eliminating CXCR4+ GBM cells: A proof of principleSemantic proximity Read ↗

Lentiviral Vectors as Tools for the Study and Treatment of GlioblastomaSemantic proximity Read ↗

The translatome of Glioblastoma multiformeSemantic proximity Read ↗

[Monoclonal antibodies in high-grade gliomas].Semantic proximity Read ↗

Nanobodies targeting EGFR provide insight into conformations stabilized by glioblastoma mutations.Semantic proximity Read ↗

Inhibition of HVEM suppresses growth and invasion of mesenchymal glioblastomaSemantic proximity Read ↗

Nanobodies Targeting ABCC3 for Immunotargeted Applications in GlioblastomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.